Taken together, these studies identify the link between AngII and VSMC senescence in vivo, however it is desired to further test pharmacological or genetic senolytic (or senomorphic) treatment in AngII-dependent CVD models such as hypertension and AAA. Here, AGT is linked to triple-A syndrome.